The first measles vaccine arrived in 1963

The measles vaccine was licensed in the United States in 1963. It was developed by John Enders and his team at Boston Children's Hospital, building on decades of research into how the measles virus worked. The vaccine used a live but weakened form of the virus—called an attenuated virus—grown in laboratory cell cultures.

Before 1963, measles was a common childhood disease that killed hundreds of Americans each year and left others with permanent brain damage or deafness. The arrival of a working vaccine changed that dramatically. Within a few years of its introduction, measles cases in the United States dropped by more than 90 percent.

Key Takeaways

  • The measles vaccine was licensed in the United States in 1963 and was based on a weakened live virus developed by John Enders and his team.
  • A second, improved version called the MMR vaccine (measles, mumps, rubella combined) became available in 1971 and is what most people receive today.
  • The original 1963 vaccine required two doses given several months apart, and the timing of doses has been refined over the decades based on how well children's immune systems respond.
  • The vaccine was so effective that measles was declared eliminated from the United States in 2000, though cases still occur when the virus is brought in from other countries.

How the original 1963 vaccine worked

The 1963 measles vaccine contained a live virus that had been weakened in the laboratory so it could not cause the full disease. When injected, this weakened virus triggered the immune system to learn how to recognize and fight measles without making the person seriously ill. Most people who received the vaccine developed immunity—meaning their body could fight off real measles if they were exposed to it later.

The original vaccine required two doses. The first dose was typically given around age 1, and the second dose came several months later. This two-dose schedule was necessary because some children's immune systems did not respond fully to the first dose, and the second dose caught those who had not yet developed immunity.

The MMR vaccine replaced the single-disease version in 1971

In 1971, a new combination vaccine became available that protected against three diseases at once: measles, mumps, and rubella (German measles). This vaccine, called the MMR vaccine, used the same weakened measles virus as the 1963 version but added protection against two other serious viral diseases. Because it was more efficient—one shot instead of multiple shots for three diseases—the MMR vaccine quickly became the standard.

The MMR vaccine is what most children in the United States receive today. The schedule has been refined over the years. Currently, the first MMR dose is given at 12 to 15 months of age, and the second dose is given at 4 to 6 years old, before school entry. This timing allows the vaccine to work when children's immune systems are mature enough to respond well.

Why measles cases dropped so quickly after 1963

The measles vaccine was remarkably effective from the start. Studies showed that one dose prevented measles in about 93 percent of vaccinated children, and two doses prevented it in about 97 percent. Because measles spreads easily through the air when an infected person coughs or sneezes, vaccinating a large portion of the population meant the virus had fewer people to infect and eventually died out in communities.

By the 1980s, measles had become rare in the United States. In 2000, the disease was officially declared eliminated—meaning it no longer spread continuously in the country. However, measles still exists in other parts of the world, and cases in the United States occur when travelers bring the virus back from abroad.

What changed between 1963 and today

The basic vaccine has remained the same—a weakened live measles virus—but the way it is made and stored has improved. Modern versions are more stable and easier to transport, which matters for countries with limited refrigeration. The vaccine is now combined with mumps and rubella protection in the MMR shot, and sometimes with varicella (chickenpox) protection in the MMRV vaccine.

The recommended age for the first dose has also shifted slightly over the decades as doctors learned more about when children's immune systems respond best. The two-dose schedule has stayed consistent because it remains the most effective way to ensure protection across the widest range of children.

Why the vaccine was developed so quickly

Measles killed or disabled thousands of American children every year before the vaccine existed. The disease caused high fevers, a distinctive rash, and serious complications including pneumonia, encephalitis (brain inflammation), and permanent hearing loss. The urgency to stop measles drove researchers and funding, and John Enders' earlier work on growing viruses in laboratory cells made the vaccine possible once the measles virus was isolated and studied.

The development of the measles vaccine was part of a broader push in the 1950s and 1960s to create vaccines for major childhood diseases. Polio vaccine had arrived in the 1950s, and the measles vaccine followed. This period saw some of the fastest vaccine development in history, driven by public health need and scientific advances.

Frequently Asked Questions

Is the measles vaccine still the same one from 1963?

The core vaccine—a weakened live measles virus—is the same, but it is now combined with mumps and rubella (MMR) and manufactured with modern techniques. The basic principle and effectiveness have not changed, though the way it is produced and stored has improved.

Why do children need two doses if the vaccine is so effective?

About 5 to 10 percent of children do not develop immunity after one dose, usually because their immune system was not mature enough or they had temporary interference from maternal antibodies. The second dose catches those children and ensures nearly universal protection.

Could measles come back if vaccination rates drop?

Yes. Measles spreads very easily, and if vaccination rates fall below about 95 percent in a community, the virus can spread again. This has happened in small outbreaks when vaccination rates dropped in specific areas.

Why was measles eliminated in the US but not worldwide?

The United States had widespread vaccine access, good refrigeration for storage, and a coordinated vaccination program. Many countries lack these resources, so measles still circulates in parts of Africa, Asia, and the Pacific. The virus can travel back to the US through international travel.